Company Directory / Research
PrivateFor profitResearchNacka Strand, Stockholm County, Sweden
Mabtech
Mabtech supplies a wide range of antibodies to cytokines, immunoglobulins and apolipoproteins.
- Founded
- 1986 40 years ago
- Staff
- 51-100 128 on LinkedIn
- Followers
- 6k on LinkedIn
- Funding
- - none listed
We are a Swedish company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA. To that end, we develop and produce a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. We started off in Stockholm in 1986, and our headquarters still lies in Nacka Strand, just east of the inner city. We do everything here, from research and… Read all
We are a Swedish company developing immunoassays for life science research. Our goal is to aid research by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA. To that end, we develop and produce a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. We started off in Stockholm in 1986, and our headquarters still lies in Nacka Strand, just east of the inner city. We do everything here, from research and production to finance, IT, quality control, marketing, distribution, and sales. In addition, we have a sales office in Cincinnati, Ohio, and collaborate with great distributors around the globe. The quality of our products really comes down to our entire organization; the balance between individual action and care for the collective. Because for us, quality isn’t just a word. It’s a mindset, a mantra, and a lens we hold to all our initiatives, whatever the size. As part of the scientific community, we want to do our share to help science progress. So we hope you see us as peers – feel free to strike up any sort of conversation with us.
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed. 128 people list it on LinkedIn.
Age
40 years old.
Reach
Website ranked #2,284,951 in the world for traffic, about 9k visits a month. 5,823 followers on LinkedIn.
What it does
BiotechnologyLife ScienceManufacturingProduct ResearchTherapeuticsMonoclonal antibodiesELISpotFluoroSpotELISASpot analysisimmunoassaysreaderELISpot readerFluoroSpot readerimmune responsesFociSpotAssay developmentcustomized services
Funding, as listed
Undisclosed raised in total
- Rounds2
- LatestDebt financing, Dec 2019
- Investors3, 2 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Mabtech, field by field. Contact details are held but never shown.
The company
- Name
- Mabtech
- Type
- For profit
- Status
- Private
- Founded
- 1986
- Founders
- Kjell Östrand
- Industry
- Research
- Categories
- Biotechnology, Life Science, Manufacturing, Product Research, Therapeutics
- Specialities
- Monoclonal antibodies, ELISpot, FluoroSpot, ELISA, Spot analysis, immunoassays, reader, ELISpot reader, FluoroSpot reader, immune responses, FociSpot, Assay development, customized services, Antibody development
Where
- City
- Nacka Strand
- Region
- Stockholm County
- Country
- Sweden
- Markets
- European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Size and reach
- Staff band
- 51-100
- People on LinkedIn
- 128
- LinkedIn followers
- 5,823
- Web traffic rank
- #2,284,951
- Monthly web visits
- 8,671
- Apps
- 5
- App downloads
- 5,091
Funding, as listed
- Rounds
- 2
- Latest round
- Debt financing
- Latest round date
- Dec 2019
- Investors
- 3
- Lead investors
- 2
- Listing status
- private
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Mabtech may be growing as it has been acquired by EQT as part of their new health-care growth strategy. The acquisition by a significant investment firm like EQT suggests a positive valuation and potential for expansion under new ownership. This strategic move indicates that Mabtech is considered a valuable asset within the healthcare sector, aligning with EQT's objectives to target the space between buyouts and venture capital with their new healthcare private equity strategy.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Research in Sweden.
Polymer FactoryStockholm · 1-10 people · 1k followers
RenFuelStockholm · 1-10 peopleSStockholm UniversityStockholm · 278k followersRRISEGöteborg · 1001-5000 people · 143k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 41,197 companies in Sweden and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.